Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
1Customers
1Debt Items
0Related Chains
Source-Backed Evidence Depth
Jyong Biotech Ltd. (MENS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
4Total relationships
1Distinct source URLs
3High confidence
0.835Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Jyong Biotech Ltd. Suppliers
Ticker
Name
Confidence
Evidence
SUPPLIER-OF-API-1
SUPPLIER-OF-API-1
92%
Active pharmaceutical ingredient-1 (API-1), the raw material we used in the previous clinical trials for Botreso®, is currently unavailable due to the supplier’s relocation and withdrawal of their co…
Jyong Biotech Ltd. Customers
Ticker
Name
Confidence
Evidence
EXPIRATION-DATE-PHARMACEUTICAL-MANUFACTURING-LIC
EXPIRATION-DATE-PHARMACEUTICAL-MANUFACTURING-LIC
62%
API-1 and API-2 are similar and comparable, we will sign the Quality Agreement with this supplier for the raw materials for API-2. We will only be able to proceed with the Phase III PCP study after t…
Jyong Biotech Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
MENS-DEBT
Debt stack $17.5M
90%
Market cache reports total debt of $17.5M.
Jyong Biotech Ltd. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Jyong Biotech Ltd..
Jyong Biotech Ltd. Ownership
Holder
Name
Confidence
Evidence
MENS-OWNER-BLACKROCK-INC
BlackRock, Inc.
90%
13F overlay lists BlackRock, Inc. as top holder; 17 tracked holders.
Jyong Biotech Ltd. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
